Enterprise considers strategic investor for Polfa Kutno

According to rumors Enterprise Investors, which holds 49% of the voting shares will make a decision soon on Polfa Kutno. For the time being, Polfa Kutno has started cooperation with a U.S.-based company Merck. Under a licensing agreement with Mreck, Polfa Kutno will manufacture some new products. However, there is speculation the cooperation with Merck will go beyond collaboration and could lead to the U.S. company becoming a strategic investor. (Prawo i Gospodarka, page 11)